Aortic Valve Replacement: Understanding TAVR vs. Open Surgery (SAVR)

When Your Aortic Valve Stops Working

Your aortic valve is the final gateway between your heart and the rest of your body. With every heartbeat, it opens to let oxygen-rich blood flow into the aorta, then snaps shut to prevent backflow. It does this roughly 100,000 times per day, over 3 billion times in an average lifetime.

Aortic stenosis — the progressive narrowing and stiffening of this valve — is the most common heart valve disease in developed countries. It affects approximately 2–3% of adults over 65, and its prevalence rises steeply with age. When the valve becomes severely narrowed, the heart must work dramatically harder to push blood through the restricted opening. Without treatment, severe symptomatic aortic stenosis carries a grim prognosis: roughly 50% mortality within two years.

The good news: aortic valve replacement options have never been better. Two proven approaches exist, and understanding both is essential to making the right decision for your situation.

When Does the Valve Need to Be Replaced?

Not every patient with aortic stenosis needs immediate surgery. Your cardiologist will typically recommend valve replacement when:

• You have symptoms. The classic triad of severe aortic stenosis includes chest pain (angina), fainting or near-fainting (syncope), and shortness of breath with exertion (dyspnea). Once symptoms appear, the clock is ticking.
• Your valve area is critically reduced. A normal aortic valve opens to 3–4 cm². Severe stenosis is defined as a valve area below 1.0 cm², a mean gradient above 40 mmHg, or a peak velocity above 4.0 m/s on echocardiography.
• Your heart is starting to weaken. Even without classic symptoms, a declining ejection fraction (below 50%) in the setting of severe stenosis is an indication for intervention.

If you have been told you need a valve replacement, you will likely be presented with two options: TAVR or SAVR.

SAVR: The Proven Standard — Open Surgical Valve Replacement

Surgical aortic valve replacement (SAVR) has been performed for over 60 years. It remains one of the most well-studied and successful cardiac operations in medicine.

What Happens During SAVR

SAVR is performed through a sternotomy — an incision through the breastbone that provides direct access to the heart. The patient is placed on cardiopulmonary bypass (the heart-lung machine), the heart is temporarily stopped, the diseased valve is cut out, and a new valve is sewn into place. The operation typically takes 3–5 hours.

What to Expect as a Patient

• Hospital stay: Typically 5–7 days, including 1–2 days in the ICU
• Recovery: Full sternal healing takes 6–8 weeks. Most patients return to normal activities within 2–3 months.
• Durability: This is where SAVR truly excels. Bioprosthetic surgical valves have documented durability of 15–20+ years. Mechanical valves can last a lifetime.
• Proven track record: Decades of long-term outcome data across hundreds of thousands of patients

Valve Choices in SAVR: Mechanical vs. Bioprosthetic

With SAVR, you typically choose between two valve types:

• Mechanical valves are made from carbon and titanium. They last indefinitely but require lifelong blood thinner medication (warfarin) with regular INR monitoring. They produce an audible click that most patients adapt to over time.
• Bioprosthetic valves are made from bovine (cow) or porcine (pig) tissue. They do not require lifelong blood thinners, but they do degenerate over time. Expected lifespan is 15–20 years, meaning younger patients may eventually need a second operation.

The choice between mechanical and bioprosthetic valves depends on your age, lifestyle, ability to take blood thinners, and personal preference. Generally, patients under 50 are considered for mechanical valves, while those over 65 typically receive bioprosthetic valves.

TAVR: The Less Invasive Alternative

Transcatheter aortic valve replacement (TAVR) — also called TAVI in some countries — has transformed the treatment of aortic stenosis since its first-in-human use in 2002. It is now one of the most commonly performed cardiac procedures worldwide.

What Happens During TAVR

TAVR is performed without opening the chest. A catheter is inserted through an artery — usually the femoral artery in the groin — and threaded up to the heart. A collapsible replacement valve, mounted on a balloon or self-expanding frame, is positioned inside the diseased native valve and deployed. The entire procedure typically takes 1–2 hours.

What to Expect as a Patient

• Hospital stay: 1–3 days, often with a next-day discharge protocol
• Recovery: Most patients are walking the same day and return to normal activities within 1–2 weeks
• Anesthesia: Many TAVR procedures are now performed under conscious sedation rather than general anesthesia
• No sternotomy: No bone is cut, which eliminates the 6–8 week sternal healing period

TAVR Considerations

TAVR has clear advantages in recovery speed and less surgical trauma, but there are important tradeoffs:

• Long-term durability data is still maturing. TAVR valves have strong 5–10 year data, but they have not yet matched the 20+ year track records of surgical bioprosthetic valves. For patients in their 50s or 60s, this uncertainty matters.
• Higher rates of permanent pacemaker implantation — roughly 10–20% of TAVR patients require a new pacemaker after the procedure, compared to 3–5% with SAVR.
• Paravalvular leak — Because the TAVR valve is not sewn in, small leaks around the valve frame can occur. Severe leak is uncommon with current-generation devices but remains a consideration.
• Vascular complications — The large catheter required can injure the access artery, though this risk has decreased significantly with smaller-profile delivery systems.

How Your Doctors Decide: TAVR vs. SAVR

The decision between TAVR vs SAVR is not one-size-fits-all. Guidelines from the American College of Cardiology and the American Heart Association provide a framework based on surgical risk and other factors:

STS Score Thresholds

• Low surgical risk (STS < 4%) — Both TAVR and SAVR are options. Recent trials (PARTNER 3, Evolut Low Risk) showed comparable outcomes at 2 years, though long-term data favoring SAVR's durability remains a factor. Patients under 65 are generally better served by SAVR.
• Intermediate risk (STS 4–8%) — Both approaches are reasonable. TAVR offers faster recovery; SAVR offers proven long-term durability. Your anatomy, age, and preferences guide the choice.
• High risk (STS > 8%) — TAVR is generally preferred due to lower procedural morbidity. The faster recovery is especially valuable in frailer patients.
• Prohibitive risk — TAVR is the only option for patients deemed too high-risk for open surgery.

Beyond the STS Score

Risk scores are a starting point, not the final word. Other critical factors include:

• Anatomy: Bicuspid aortic valves, heavy calcification patterns, small or large annulus size, and peripheral vascular disease all influence which approach is safer and more effective.
• Age and life expectancy: A 55-year-old will likely outlive a TAVR valve. A 90-year-old needs the least invasive option possible.
• Concomitant disease: If you also need coronary bypass surgery or another valve repair, SAVR with combined surgery may be the more efficient single-operation approach.
• Prior cardiac surgery: Patients who have already had a sternotomy face higher risk with repeat open surgery, tilting the balance toward TAVR.

Recovery: A Side-by-Side Comparison

Long-Term Outcomes

Both TAVR and SAVR dramatically improve survival compared to medical therapy alone in patients with severe symptomatic aortic stenosis. The key outcome differences are:

• Survival at 5 years is comparable between TAVR and SAVR in most risk categories studied to date.
• Stroke rates have historically been slightly higher with TAVR, though newer devices and cerebral embolic protection strategies are narrowing this gap.
• Reoperation rates — SAVR valves rarely need replacement within 15 years. TAVR long-term reoperation data is still being collected, but structural valve deterioration appears to begin emerging after 7–10 years in some patients.

When a Second Opinion Is Critical

Not every aortic valve replacement decision is straightforward. A second opinion on your aortic valve replacement options is especially important if:

• You are in the borderline zone — intermediate risk, age 65–75, or features that could reasonably support either approach
• You have received conflicting recommendations — one doctor says TAVR, another says SAVR
• Your procedure is planned at a low-volume center — outcomes for both TAVR and SAVR are significantly better at high-volume centers (more than 100 TAVR cases or 50+ SAVR cases per year)
• You have a bicuspid valve — TAVR in bicuspid anatomy requires specific expertise and device selection
• You are under 65 — the long-term durability question becomes paramount for younger patients

These are exactly the cases where an independent, expert-level review can change the trajectory of your care.

Facing an aortic valve replacement decision? Get a WhiteGloveMD second opinion from a Heart Team that reviews your complete records, calculates your individualized risk, and delivers a clear recommendation within 48 hours. Because the right valve — placed the right way — is a decision that shapes the rest of your life.